Publication:
Fourth versus eighth week surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: Istanbul R-01 study

dc.contributor.coauthorSağlam, Sezer
dc.contributor.coauthorSağlam, Esra K.
dc.contributor.coauthorAsoğlu, Oktar
dc.contributor.coauthorBalık, Emre
dc.contributor.coauthorYamaner, Sümer
dc.contributor.coauthorBaşaran, Mert
dc.contributor.coauthorOral, Ethem N.
dc.contributor.coauthorKizir, Ahmet
dc.contributor.coauthorKapran, Yersu
dc.contributor.coauthorGüllüoğlu, Mine
dc.contributor.coauthorSakar, Burak
dc.contributor.coauthorBulut, Türker
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorBuğra, Dursun
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:35:41Z
dc.date.issued2014
dc.description.abstractBackground and purpose: The optimum duration between neoadjuvant radiochemotherapy and transmesorectal excision in locally advanced rectal cancer has not been defined yet. This randomized study was designed to compare the efficacy of four-week versus eight-week delay before surgery.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue1
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume5
dc.identifier.doi10.3978/j.issn.2078-6891.2013.025
dc.identifier.eissn2219-679X
dc.identifier.issn2078-6891
dc.identifier.quartileQ4
dc.identifier.scopus2-s2.0-84907304349
dc.identifier.urihttps://doi.org/10.3978/j.issn.2078-6891.2013.025
dc.identifier.urihttps://hdl.handle.net/20.500.14288/12540
dc.identifier.wos219291800010
dc.keywordsRectal carcinoma
dc.keywordsNeoadjuvant radiochemotherapy
dc.keywordsNeoadjuvant-surgery interval
dc.keywordsSurgical margin positivity
dc.keywordsSurvival
dc.keywordsLocal control
dc.language.isoeng
dc.publisherAME Publishing Company
dc.relation.ispartofJournal of Gastrointestinal Oncology
dc.subjectOncology
dc.subjectGastroenterology
dc.subjectHepatology
dc.titleFourth versus eighth week surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: Istanbul R-01 study
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorBuğra, Dursun
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files